535 related articles for article (PubMed ID: 21934353)
1. Pancreatic progenitors: The shortest route to restore islet cell mass.
Venkatesan V; Gopurappilly R; Goteti SK; Dorisetty RK; Bhonde RR
Islets; 2011; 3(6):295-301. PubMed ID: 21934353
[TBL] [Abstract][Full Text] [Related]
2. Can pancreatic duct-derived progenitors be a source of islet regeneration?
Xia B; Zhan XR; Yi R; Yang B
Biochem Biophys Res Commun; 2009 Jun; 383(4):383-5. PubMed ID: 19324022
[TBL] [Abstract][Full Text] [Related]
3. Islet-derived progenitors as a source of in vitro islet regeneration.
Hanley S; Rosenberg L
Methods Mol Biol; 2009; 482():371-85. PubMed ID: 19089368
[TBL] [Abstract][Full Text] [Related]
4. Development of cell markers for the identification and expansion of islet progenitor cells.
Zhang YQ; Sarvetnick N
Diabetes Metab Res Rev; 2003; 19(5):363-74. PubMed ID: 12951644
[TBL] [Abstract][Full Text] [Related]
5. New sources of pancreatic beta-cells.
Bonner-Weir S; Weir GC
Nat Biotechnol; 2005 Jul; 23(7):857-61. PubMed ID: 16003374
[TBL] [Abstract][Full Text] [Related]
6. Progenitor cells in the adult pancreas.
Holland AM; Góñez LJ; Harrison LC
Diabetes Metab Res Rev; 2004; 20(1):13-27. PubMed ID: 14737742
[TBL] [Abstract][Full Text] [Related]
7. Identification and expansion of pancreatic stem/progenitor cells.
Zhang YQ; Kritzik M; Sarvetnick N
J Cell Mol Med; 2005; 9(2):331-44. PubMed ID: 15963253
[TBL] [Abstract][Full Text] [Related]
8. The role of renin-angiotensin system in cellular differentiation: implications in pancreatic islet cell development and islet transplantation.
Wang L; Leung PS
Mol Cell Endocrinol; 2013 Dec; 381(1-2):261-71. PubMed ID: 23994025
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cells promote pancreatic stem cell activation during islet regeneration in mice.
Rivas-Carrillo SD; Kanamune J; Iwanaga Y; Uemoto S; Daneri-Navarro A; Rivas-Carrillo JD
Transplant Proc; 2011 Nov; 43(9):3209-11. PubMed ID: 22099759
[TBL] [Abstract][Full Text] [Related]
10. Research status and prospect of stem cells in the treatment of diabetes mellitus.
Liu X; Wang Y; Li Y; Pei X
Sci China Life Sci; 2013 Apr; 56(4):306-12. PubMed ID: 23564185
[TBL] [Abstract][Full Text] [Related]
11. Stem cells and pancreatic differentiation in vitro.
Blyszczuk P; Wobus AM
J Biotechnol; 2004 Sep; 113(1-3):3-13. PubMed ID: 15380643
[TBL] [Abstract][Full Text] [Related]
12. Islet formation and regeneration.
Yang KM; Li AD; Mei Y; Zhou HY; Li H; Yang HJ
Chin Med Sci J; 2006 Mar; 21(1):27-32. PubMed ID: 16615281
[TBL] [Abstract][Full Text] [Related]
13. Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas.
Bouwens L
Microsc Res Tech; 1998 Nov; 43(4):332-6. PubMed ID: 9849974
[TBL] [Abstract][Full Text] [Related]
14. Regenerative medicine of the pancreatic beta cells.
Yamada S; Kojima I
J Hepatobiliary Pancreat Surg; 2005; 12(3):218-26. PubMed ID: 15995810
[TBL] [Abstract][Full Text] [Related]
15. Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization.
Bell GI; Broughton HC; Levac KD; Allan DA; Xenocostas A; Hess DA
Stem Cells Dev; 2012 Jan; 21(1):97-109. PubMed ID: 21417581
[TBL] [Abstract][Full Text] [Related]
16. Lineage tracing of pancreatic stem cells and beta cell regeneration.
Houbracken I; Mathijs I; Bouwens L
Methods Mol Biol; 2012; 933():303-15. PubMed ID: 22893416
[TBL] [Abstract][Full Text] [Related]
17. Patients with chronic pancreatitis have islet progenitor cells in their ducts, but reversal of overt diabetes in NOD mice by anti-CD3 shows no evidence for islet regeneration.
Phillips JM; O'Reilly L; Bland C; Foulis AK; Cooke A
Diabetes; 2007 Mar; 56(3):634-40. PubMed ID: 17327430
[TBL] [Abstract][Full Text] [Related]
18. Stem cell applications in diabetes.
Noguchi H
J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
[TBL] [Abstract][Full Text] [Related]
19. Stem-cell therapy for diabetes mellitus.
Hussain MA; Theise ND
Lancet; 2004 Jul 10-16; 364(9429):203-5. PubMed ID: 15246735
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells.
Liang J; Leung KK; Lam SY; Leung PS
Diabetes Obes Metab; 2012 Sep; 14(9):842-51. PubMed ID: 22519909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
